Medtronic gets boost as US DoJ closes Infuse investigation
This article was originally published in Clinica
Executive Summary
Medtronic has had a rare piece of good news relating to its Infuse bone graft, after the US Department of Justice closed its investigation into the troubled product. The investigation, which also involved the US Attorney for the District of Massachusetts, relates to claims that Medtronic promoted off-label use of Infuse.